1,1-Diethoxycyclohexane, 98%, 5g

8-Bromoquinazoline-2,4-diol, 95.0%, 1g

2-((5-Ethyl-4-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)thio)-N-(4-(4-methoxyphenyl)thiazol-2-yl)acetamide, 95+%, 25mg

2-METHYL-4-METHYLSULFONYLANILINE, 95%, 5g

6-(Hydroxymethyl)pyridin-3-ol, 95.0%, 250mg

Larazotide Acetate, 98%, 50mg

Ácido n-valérico, mínimo 98 %, 250 ml, envase de vidrio

4-Bromo-1-propyl-1H-imidazole, 95.0%, 1g

1,3-Dithiane>97.0%(GC)25g

Methyl 4-Acetamido-2-methoxybenzoate>98.0%(GC)5g

4-Bromo-7-chlorobenzo[d]thiazole, 250mg

(R)-2,3-Bis((((9H-fluoren-9-yl)methoxy)carbonyl)amino)propanoic acid, 95%, 1g

Cuba de muestra, 150 ml, No estéril, 120 Unidad(es)